Keywords: mixed, trial, results, actelion, tracleer, swiss, drugmaker

Mixed trial results for Actelion's Tracleer

Article | 05 December 2005

Swiss drugmaker Actelion says that, in recent trials of Tracleer (bosentan), the firm's dual endothelin receptor antagonist, in patients suffering ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bosentan

Tracleer

Go to drug listing